NPPES file of Aug 9, 2026

Kavitha Ganesan, M.D.

Endocrinology, Diabetes & Metabolism Physician · Tyler, TX

Kavitha Ganesan, M.D. is an endocrinology, diabetes & metabolism physician with a practice address in Tyler, Texas, and NPI 1427402551, issued on Apr 14, 2016. Check the license (Texas U9924, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1427402551
Name
Kavitha Ganesan
Credential
M.D.
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
U9924 TX
Self-reported in NPPES; status is on the state search
Practice location
11937 US Highway 271, Tyler, TX 75708
Phone
(903) 877-7200
Enumerated
Apr 14, 2016
Record last updated
Jul 11, 2024
Medicare enrollment
Enrolled (PECOS I20240709003713); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 11937 US Highway 271

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Cynthia Ackley, RDRegistered Dietitian1538507892
  2. Linda Ahaiwe, DOStudent in an Organized Health Care Education/Training Program1114615408
  3. Arbab Ahmed, MDStudent in an Organized Health Care Education/Training Program1356279608
  4. Rahman Ahmed, DOInternal Medicine Physician1912644279
  5. Ibrahim Al-Hashimi, MDStudent in an Organized Health Care Education/Training Program1982341095
  6. Michael Alchaer, MDStudent in an Organized Health Care Education/Training Program1922809417

Verify Kavitha Ganesan in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license U9924
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

64% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

954 Medicare Part D claims for 220 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 41% of claims.

  1. Kavitha Ganesan954
  2. Specialty average2,630

Most prescribed

  1. Levothyroxine Sodium191 claims
  2. Ozempic42 claims
  3. Lantus Solostar41 claims
  4. Methimazole39 claims
  5. Novolog Flexpen38 claims
  6. Pioglitazone Hcl38 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 76.7 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score78.6
  2. Costout of 100 · 30%44.6
  3. Promoting interoperabilityout of 100 · 25%99.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $827.77

35 payments; by number, the most common kind was food and beverage; the largest payer was Nevro Corp. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Kavitha Ganesan$827.77
  2. Specialty average$5,742.15

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. University OF Texas Health Science Center AT Tyler-Facilty-PhysicianTyler, TX

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Kavitha Ganesan among 743 endocrinology, diabetes & metabolism physician records in Texas

Kavitha Ganesan, M.D. is one of 743 endocrinology, diabetes & metabolism physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2016, is newer than 84% of them.

  • NPI issued2016 · 84% of these records are older, 13% newer
  • In a Medicare fileYes · 87% of these records are
  • In the CMS Doctors and Clinicians fileYes · 75% of these records are
  • Graduated2008 · median 2004 among the 560 with a school on file
  • Record last updated2024 · 50% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in Texas

There are 743 endocrinology, diabetes & metabolism physician records in Texas.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Mingxue ArguelloTyler, TX 757081164882429
  2. Larry Wiertz, M.D.Tyler, TX 757031104928019
  3. Jeffrey Jackson, MDTyler, TX 757021972563443
  4. Luis Arce, MDTyler, TX 757011053381418
  5. Kyle Jackson, D.O.Tyler, TX 757011548569056
  6. Sylvia Kariampuzha, MDTyler, TX 757011316911381
  7. Maxwell Kwaku, MDTyler, TX 757011083641534
  8. Deborah Osafehinti, M.B.CH.BTyler, TX 757011548764293

Common questions

What is Kavitha Ganesan, M.D.'s NPI number?

Kavitha Ganesan, M.D.'s National Provider Identifier (NPI) is 1427402551, issued on Apr 14, 2016. An NPI identifies a provider in billing; it is not a license.

Where is Kavitha Ganesan, M.D. located?

The NPPES record lists a practice address at 11937 US Highway 271, Tyler, TX, 75708. Phone: (903) 877-7200. Providers update this record themselves, so call before visiting.

How can I verify Kavitha Ganesan, M.D.'s license?

NPPES lists Texas license number U9924, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Kavitha Ganesan, M.D. prescribe under Medicare Part D?

In 2024, Kavitha Ganesan, M.D. had 954 Medicare Part D claims for 220 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

What is Kavitha Ganesan, M.D.'s MIPS final score?

The 2023 MIPS final score is 76.7 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.